Jennison Associates
SILK

Jennison Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Jennison Associates’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-540,612
Closed -$8.1M – 631
2023
Q3 		$8.1M Buy
540,612
+3,748
+0.7% +$78K 0.01% 383
2023
Q2 		$17.4M Sell
536,864
-360,092
-40% -$13.1M 0.01% 333
2023
Q1 		$35.1M Buy
896,956
+220,833
+33% +$10.8M 0.03% 241
2022
Q4 		$35.7M Sell
676,123
-9,921
-1% -$483K 0.04% 236
2022
Q3 		$30.9M Buy
686,044
+235,762
+52% +$10.1M 0.03% 250
2022
Q2 		$16.4M Sell
450,282
-234,488
-34% -$8.52M 0.02% 334
2022
Q1 		$28.3M Sell
684,770
-5,052
-0.7% -$178K 0.02% 307
2021
Q4 		$29.4M Buy
689,822
+113,974
+20% +$5.7M 0.02% 298
2021
Q3 		$31.7M Buy
575,848
+356,271
+162% +$18.6M 0.02% 291
2021
Q2 		$10.5M Sell
219,577
-144,200
-40% -$7.35M 0.01% 450
2021
Q1 		$18.4M Sell
363,777
-760,503
-68% -$42.3M 0.01% 364
2020
Q4 		$70.8M Sell
1,124,280
-130,483
-10% -$8.1M 0.05% 151
2020
Q3 		$84.3M Sell
1,254,763
-279,978
-18% -$15.3M 0.07% 111
2020
Q2 		$64.3M Buy
1,534,741
+198,912
+15% +$7.64M 0.06% 131
2020
Q1 		$42.1M Buy
1,335,829
+109,966
+9% +$4.4M 0.05% 164
2019
Q4 		$49.5M Buy
1,225,863
+181,977
+17% +$6.37M 0.05% 190
2019
Q3 		$34M Buy
1,043,886
+617,337
+145% +$24.6M 0.04% 242
2019
Q2 		$20.7M Buy
+426,549
New +$18.1M 0.02% 348

Other funds holding SILK

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Jennison Associates's SILK Position: Q4 2023 in Review

Jennison Associates sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q4 2023, closing a stake of 540,612 shares — an estimated $8.1M sold.

Jennison Associates first reported a position in SILK in Q2 2019 and held it in 18 quarters. The position peaked at $84.3M in Q3 2020. 133 funds tracked by Wall St. Rank hold SILK as of Q4 2023.

  • Jennison Associates reported no remaining Silk Road Medical, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Jennison Associates sold 540,612 Silk Road Medical, Inc. Common Stock shares in Q4 2023, an estimated $8.1M.
  • Jennison Associates first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2019 and held it in 18 quarters.
  • Jennison Associates's Silk Road Medical, Inc. Common Stock position peaked at $84.3M in Q3 2020.
  • 133 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q4 2023.

Based on Jennison Associates's 13F filing for Q4 2023, filed 1 Feb 2024.